Correlation Between Pasithea Therapeutics and Seres Therapeutics

Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pasithea Therapeutics Corp and Seres Therapeutics, you can compare the effects of market volatilities on Pasithea Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Seres Therapeutics.

Diversification Opportunities for Pasithea Therapeutics and Seres Therapeutics

-0.27

Correlation Coefficient

Pasithea Therapeutics  Seres Therapeutics

Very good diversification

The 3 months correlation between Pasithea and Seres is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Seres Therapeutics go up and down completely randomly.

Pair Corralation between Pasithea Therapeutics and Seres Therapeutics

Assuming the 90 days horizon Pasithea Therapeutics Corp is expected to generate 4.49 times more return on investment than Seres Therapeutics. However, Pasithea Therapeutics is 4.49 times more volatile than Seres Therapeutics. It trades about 0.18 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.09 per unit of risk. If you would invest  1.13  in Pasithea Therapeutics Corp on September 3, 2024 and sell it today you would earn a total of  0.90  from holding Pasithea Therapeutics Corp or generate 79.65% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	50.0%
Values	Daily Returns

Pasithea Therapeutics Corp  vs.  Seres Therapeutics

Pasithea Therapeutics

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Pasithea Therapeutics Corp are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Pasithea Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Seres Therapeutics

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Seres Therapeutics are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Seres Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pasithea Therapeutics and Seres Therapeutics

The main advantage of trading using opposite Pasithea Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.

The idea behind Pasithea Therapeutics Corp and Seres Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.